Infections simulating immune checkpoint inhibitor toxicities: Uncommon and deceptive

Use of Immune checkpoint inhibitors (ICIs), a revolutionary treatment in modern oncology, is frequently complicated by immune-related adverse events (irAEs), which can be confused with infections, and vice versa, thus complicating management decisions. Herein we review the published cases of infections as simulators of irAEs in cancer patients.